Timothy Van Hauwermeiren

Insider Reports History

Entity
Individual
Location
C/O Iteos Therapeutics, Inc., 139 Main Street, Cambridge, MA
Signature
/s/ Youjin Choi, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Timothy Van Hauwermeiren:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Lexeo Therapeutics, Inc. Director Stock Option (right to buy) 36K Jul 5, 2024 Direct
iTeos Therapeutics, Inc. Director Stock Option (Right to Buy) 24.2K Jun 11, 2024 Direct
RayzeBio, Inc. Director Stock Option (Right to Buy) 0 Feb 26, 2024 Direct

Insider Reports Filed by Timothy Van Hauwermeiren

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LXEO Lexeo Therapeutics, Inc. Jul 5, 2024 1 $0 4 Jul 8, 2024 Director
LXEO Lexeo Therapeutics, Inc. Jul 5, 2024 0 $0 3 Jul 8, 2024 Director
ITOS iTeos Therapeutics, Inc. Jun 11, 2024 1 $0 4 Jun 13, 2024 Director
RYZB RayzeBio, Inc. Feb 26, 2024 1 $0 4 Feb 27, 2024 Director
RYZB RayzeBio, Inc. Nov 1, 2023 1 $0 4 Nov 1, 2023 Director
RYZB RayzeBio, Inc. Nov 1, 2023 0 $0 3 Nov 1, 2023 Director
ITOS iTeos Therapeutics, Inc. Jun 13, 2023 1 $0 4 Jun 15, 2023 Director
ITOS iTeos Therapeutics, Inc. Jun 9, 2022 1 $0 4 Jun 10, 2022 Director
ITOS iTeos Therapeutics, Inc. Jun 17, 2021 1 $0 4 Jun 21, 2021 Director